[Acute coronary ischemic syndrome without ST elevation. Role of glycoprotein IIB/IIIA inhibitors and percutaneous coronary interventions].
Myocardial infarction without ST elevation and unstable angina, represents a diagnostic challenge. This Syndromes are caused by rupture of a vulnerable plaque which determines intraluminal thrombosis, distal embolism and coronary obstruction. Administration of IIb/IIIa inhibitors produces some benefits, mainly in those patients who are taking to catheterization. Coronary intervention based on a routine invasive strategy, has decreased major cardiac events principally at long term.
Peña Duque
Marco Antonio
MA
Departamento de Hemodinámica, Instituto Nacional de Cardiología Ignacio Chávez, Tlalpan, DF México.
D000208:Acute Disease; D000789:Angina, Unstable / Q000628:therapy*; D015906:Angioplasty, Balloon, Coronary; D006801:Humans; D009203:Myocardial Infarction / Q000628:therapy*; D017202:Myocardial Ischemia / Q000628:therapy*; D019039:Platelet Glycoprotein GPIIb-IIIa Complex / Q000037:antagonists & inhibitors*; D013577:Syndrome
D019039:Platelet Glycoprotein GPIIb-IIIa Complex